期刊
ELIFE
卷 6, 期 -, 页码 -出版社
ELIFE SCIENCES PUBLICATIONS LTD
DOI: 10.7554/eLife.26152
关键词
-
类别
资金
- Medical Research Council [MC_PC_U127580973, MC_PC_U127574433]
- Howard Hughes Medical Institute [IECS-55007420]
- Wellcome [ISSF3]
- Max-Planck-Gesellschaft
- Kreftforeningen [2293664-2011]
- Universitetet i Oslo
- Ministerio de Economia y Competitividad [FIS-FEDER-PI11/01489, FIS-FEDER-PI14/02152]
- H2020 European Research Council ERC [ERC-STG-2012-233764]
- Seventh Framework Programme [PCIN-2014-115-ERA-NET]
- Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia [CICE-FEDER-P12-CTS-2256]
- Medical Research Council [1232691, MC_PC_U127574433, MC_PC_U127580973] Funding Source: researchfish
- MRC [MC_PC_U127574433, MC_PC_U127580973] Funding Source: UKRI
Mobilization of retrotransposons to new genomic locations is a significant driver of mammalian genome evolution, but these mutagenic events can also cause genetic disorders. In humans, retrotransposon mobilization is mediated primarily by proteins encoded by LINE-1 (L1) retrotransposons, which mobilize in pluripotent cells early in development. Here we show that TEX19.1, which is induced by developmentally programmed DNA hypomethylation, can directly interact with the L1-encoded protein L1-ORF1p, stimulate its polyubiquitylation and degradation, and restrict L1 mobilization. We also show that TEX19.1 likely acts, at least in part, through promoting the activity of the E3 ubiquitin ligase UBR2 towards L1-ORF1 p. Moreover, loss of Tex19.1 increases L1-ORF1p levels and L1 mobilization in pluripotent mouse embryonic stem cells, implying that Tex19.1 prevents de novo retrotransposition in the pluripotent phase of the germline cycle. These data show that post-translational regulation of L1 retrotransposons plays a key role in maintaining trans-generational genome stability in mammals.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据